Arbutus Biopharma GAAP EPS of -$0.04 misses by $0.01, revenue of $0.53M misses by $0.42M (NASDAQ:ABUS)
Arbutus BiopharmaArbutus Biopharma(US:ABUS) Seeking Alpha·2025-11-13 13:04

Group 1 - The article does not provide any specific content related to a company or industry [1]